Apolipoprotein E controls the risk and age at onset of Parkinson disease

Y. J. Li, M. A. Hauser, William K Scott, Eden R Martin, M. W. Booze, X. J. Qin, J. W. Walter, M. A. Nance, J. P. Hubble, W. C. Koller, R. Pahwa, M. B. Stern, B. C. Hiner, J. Jankovic, C. G. Goetz, G. W. Small, F. Mastaglia, J. L. Haines, Margaret A Pericak-Vance, Jeffery M Vance

Research output: Contribution to journalArticle

107 Citations (Scopus)

Abstract

Background: Similarities between Alzheimer disease (AD) and Parkinson disease (PD) suggest a possible role for apolipoprotein E (APOE) in PD. Most previous studies seeking to establish such a link used case-control datasets and results have been inconsistent. Objective: To investigate APOE's role in PD using family-based association analyses. Methods: APOE functional polymorphisms were genotyped for 658 PD affected families, including 282 multiplex and 376 singleton families. The pedigree disequilibrium test (PDT) and the genotype-PDT were used to test the risk effect of APOE. The Monks-Kaplan test was used to evaluate the effect of APOE on age at onset of PD. Results: APOE was significantly associated with risk of developing PD. Stratified analysis revealed that APOE was most strongly associated with families with a positive PD family history (global p = 0.003). Like AD, the APOE-4 allele increases disease risk while the APOE-3 allele decreases risk. We detected a positive association of APOE-3 (p = 0.019) and a negative association of APOE-4 (p = 0.015) with age at onset in PD. Conclusions: The APOE-4 allele increases risk and decreases age at onset of PD, an association that may not be dependent upon cognitive impairment.

Original languageEnglish
Pages (from-to)2005-2009
Number of pages5
JournalNeurology
Volume62
Issue number11
StatePublished - Jun 8 2004
Externally publishedYes

Fingerprint

Apolipoproteins E
Parkinson Disease
Apolipoprotein E4
Apolipoprotein E3
Alleles
Pedigree
Alzheimer Disease
Parkinson Disease 10
Genotype

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Apolipoprotein E controls the risk and age at onset of Parkinson disease. / Li, Y. J.; Hauser, M. A.; Scott, William K; Martin, Eden R; Booze, M. W.; Qin, X. J.; Walter, J. W.; Nance, M. A.; Hubble, J. P.; Koller, W. C.; Pahwa, R.; Stern, M. B.; Hiner, B. C.; Jankovic, J.; Goetz, C. G.; Small, G. W.; Mastaglia, F.; Haines, J. L.; Pericak-Vance, Margaret A; Vance, Jeffery M.

In: Neurology, Vol. 62, No. 11, 08.06.2004, p. 2005-2009.

Research output: Contribution to journalArticle

Li, YJ, Hauser, MA, Scott, WK, Martin, ER, Booze, MW, Qin, XJ, Walter, JW, Nance, MA, Hubble, JP, Koller, WC, Pahwa, R, Stern, MB, Hiner, BC, Jankovic, J, Goetz, CG, Small, GW, Mastaglia, F, Haines, JL, Pericak-Vance, MA & Vance, JM 2004, 'Apolipoprotein E controls the risk and age at onset of Parkinson disease', Neurology, vol. 62, no. 11, pp. 2005-2009.
Li YJ, Hauser MA, Scott WK, Martin ER, Booze MW, Qin XJ et al. Apolipoprotein E controls the risk and age at onset of Parkinson disease. Neurology. 2004 Jun 8;62(11):2005-2009.
Li, Y. J. ; Hauser, M. A. ; Scott, William K ; Martin, Eden R ; Booze, M. W. ; Qin, X. J. ; Walter, J. W. ; Nance, M. A. ; Hubble, J. P. ; Koller, W. C. ; Pahwa, R. ; Stern, M. B. ; Hiner, B. C. ; Jankovic, J. ; Goetz, C. G. ; Small, G. W. ; Mastaglia, F. ; Haines, J. L. ; Pericak-Vance, Margaret A ; Vance, Jeffery M. / Apolipoprotein E controls the risk and age at onset of Parkinson disease. In: Neurology. 2004 ; Vol. 62, No. 11. pp. 2005-2009.
@article{248107b4f5344b1d809b0d4ca97c70d8,
title = "Apolipoprotein E controls the risk and age at onset of Parkinson disease",
abstract = "Background: Similarities between Alzheimer disease (AD) and Parkinson disease (PD) suggest a possible role for apolipoprotein E (APOE) in PD. Most previous studies seeking to establish such a link used case-control datasets and results have been inconsistent. Objective: To investigate APOE's role in PD using family-based association analyses. Methods: APOE functional polymorphisms were genotyped for 658 PD affected families, including 282 multiplex and 376 singleton families. The pedigree disequilibrium test (PDT) and the genotype-PDT were used to test the risk effect of APOE. The Monks-Kaplan test was used to evaluate the effect of APOE on age at onset of PD. Results: APOE was significantly associated with risk of developing PD. Stratified analysis revealed that APOE was most strongly associated with families with a positive PD family history (global p = 0.003). Like AD, the APOE-4 allele increases disease risk while the APOE-3 allele decreases risk. We detected a positive association of APOE-3 (p = 0.019) and a negative association of APOE-4 (p = 0.015) with age at onset in PD. Conclusions: The APOE-4 allele increases risk and decreases age at onset of PD, an association that may not be dependent upon cognitive impairment.",
author = "Li, {Y. J.} and Hauser, {M. A.} and Scott, {William K} and Martin, {Eden R} and Booze, {M. W.} and Qin, {X. J.} and Walter, {J. W.} and Nance, {M. A.} and Hubble, {J. P.} and Koller, {W. C.} and R. Pahwa and Stern, {M. B.} and Hiner, {B. C.} and J. Jankovic and Goetz, {C. G.} and Small, {G. W.} and F. Mastaglia and Haines, {J. L.} and Pericak-Vance, {Margaret A} and Vance, {Jeffery M}",
year = "2004",
month = "6",
day = "8",
language = "English",
volume = "62",
pages = "2005--2009",
journal = "Neurology",
issn = "0028-3878",
publisher = "Lippincott Williams and Wilkins",
number = "11",

}

TY - JOUR

T1 - Apolipoprotein E controls the risk and age at onset of Parkinson disease

AU - Li, Y. J.

AU - Hauser, M. A.

AU - Scott, William K

AU - Martin, Eden R

AU - Booze, M. W.

AU - Qin, X. J.

AU - Walter, J. W.

AU - Nance, M. A.

AU - Hubble, J. P.

AU - Koller, W. C.

AU - Pahwa, R.

AU - Stern, M. B.

AU - Hiner, B. C.

AU - Jankovic, J.

AU - Goetz, C. G.

AU - Small, G. W.

AU - Mastaglia, F.

AU - Haines, J. L.

AU - Pericak-Vance, Margaret A

AU - Vance, Jeffery M

PY - 2004/6/8

Y1 - 2004/6/8

N2 - Background: Similarities between Alzheimer disease (AD) and Parkinson disease (PD) suggest a possible role for apolipoprotein E (APOE) in PD. Most previous studies seeking to establish such a link used case-control datasets and results have been inconsistent. Objective: To investigate APOE's role in PD using family-based association analyses. Methods: APOE functional polymorphisms were genotyped for 658 PD affected families, including 282 multiplex and 376 singleton families. The pedigree disequilibrium test (PDT) and the genotype-PDT were used to test the risk effect of APOE. The Monks-Kaplan test was used to evaluate the effect of APOE on age at onset of PD. Results: APOE was significantly associated with risk of developing PD. Stratified analysis revealed that APOE was most strongly associated with families with a positive PD family history (global p = 0.003). Like AD, the APOE-4 allele increases disease risk while the APOE-3 allele decreases risk. We detected a positive association of APOE-3 (p = 0.019) and a negative association of APOE-4 (p = 0.015) with age at onset in PD. Conclusions: The APOE-4 allele increases risk and decreases age at onset of PD, an association that may not be dependent upon cognitive impairment.

AB - Background: Similarities between Alzheimer disease (AD) and Parkinson disease (PD) suggest a possible role for apolipoprotein E (APOE) in PD. Most previous studies seeking to establish such a link used case-control datasets and results have been inconsistent. Objective: To investigate APOE's role in PD using family-based association analyses. Methods: APOE functional polymorphisms were genotyped for 658 PD affected families, including 282 multiplex and 376 singleton families. The pedigree disequilibrium test (PDT) and the genotype-PDT were used to test the risk effect of APOE. The Monks-Kaplan test was used to evaluate the effect of APOE on age at onset of PD. Results: APOE was significantly associated with risk of developing PD. Stratified analysis revealed that APOE was most strongly associated with families with a positive PD family history (global p = 0.003). Like AD, the APOE-4 allele increases disease risk while the APOE-3 allele decreases risk. We detected a positive association of APOE-3 (p = 0.019) and a negative association of APOE-4 (p = 0.015) with age at onset in PD. Conclusions: The APOE-4 allele increases risk and decreases age at onset of PD, an association that may not be dependent upon cognitive impairment.

UR - http://www.scopus.com/inward/record.url?scp=2942562810&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=2942562810&partnerID=8YFLogxK

M3 - Article

C2 - 15184605

AN - SCOPUS:2942562810

VL - 62

SP - 2005

EP - 2009

JO - Neurology

JF - Neurology

SN - 0028-3878

IS - 11

ER -